Patient characteristics
| Characteristics . | n . |
|---|---|
| Sex, M/F | 227/222 |
| Median age, y (range) | 53 (16-76) |
| Cytogenetics | |
| Favorable | 45 (10.0%) |
| Intermediate | 217 (48.3%) |
| Unfavorable | 59 (13.1%) |
| NA | 128 (28.5%) |
| FAB subtype | |
| M0 | 17 (3.8%) |
| M1 | 95 (21.2%) |
| M2 | 151 (33.6%) |
| M4 | 77 (17.1%) |
| M4Eo | 31 (6.9%) |
| M5a | 24 (5.3%) |
| M5b | 33 (7.3%) |
| M6 | 16 (3.6%) |
| M7 | 2 (0.4%) |
| NA | 3 (0.7%) |
| Median LDH, U/L (range) | 422 (98-5220) |
| Median bone marrow blasts day 16, % (range) | 5% (0%-100%) |
| Characteristics . | n . |
|---|---|
| Sex, M/F | 227/222 |
| Median age, y (range) | 53 (16-76) |
| Cytogenetics | |
| Favorable | 45 (10.0%) |
| Intermediate | 217 (48.3%) |
| Unfavorable | 59 (13.1%) |
| NA | 128 (28.5%) |
| FAB subtype | |
| M0 | 17 (3.8%) |
| M1 | 95 (21.2%) |
| M2 | 151 (33.6%) |
| M4 | 77 (17.1%) |
| M4Eo | 31 (6.9%) |
| M5a | 24 (5.3%) |
| M5b | 33 (7.3%) |
| M6 | 16 (3.6%) |
| M7 | 2 (0.4%) |
| NA | 3 (0.7%) |
| Median LDH, U/L (range) | 422 (98-5220) |
| Median bone marrow blasts day 16, % (range) | 5% (0%-100%) |
NA indicates not available.